<!DOCTYPE html>
<html lang="fa">
 <meta content="text/html;charset=utf-8" http-equiv="content-type"/>
 <head>
  <title>
   Overview of inherited disorders of glucose and glycogen metabolism
  </title>
  <link href="d/css/1.css" rel="stylesheet"/>
 </head>
 <body>
  <!-- Start Main Menu Area -->
  <br/>
  <br/>
  <br/>
  <br/>
  <div class="container">
   <div class="row">
   </div>
  </div>
  <section class="teacher-area ptb-10">
   <div class="container">
   </div>
   <section class="course-details-area ptb-60">
    <div class="container">
     <div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
      <h1 style="text-align:center">
       Overview of inherited disorders of glucose and glycogen metabolism
      </h1>
      <div class="utdArticleSection utdStyle" id="topicContent">
       <div id="topicTitle">
        Overview of inherited disorders of glucose and glycogen metabolism
       </div>
       <div class="authorSectionElem">
        <div class="authorsElementsLeft">
         <dl id="topicContributors">
          <dt>
           <span>
           </span>
           Authors:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            William J Craigen, MD, PhD
           </a>
          </dd>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Basil T Darras, MD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Section Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Sihoun Hahn, MD, PhD
           </a>
          </dd>
          <dt>
           <span>
           </span>
           Deputy Editor:
          </dt>
          <dd>
           <a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">
            Elizabeth TePas, MD, MS
           </a>
          </dd>
         </dl>
        </div>
        <div class="authorsElementsRight">
         <div id="literatureReviewDate">
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             Literature review current through:
            </span>
            Jan 2024.
           </bdi>
          </div>
          <div class="litReviewSingleLine">
           <bdi>
            <span class="emphasis">
             This topic last updated:
            </span>
            Jan 30, 2024.
           </bdi>
          </div>
         </div>
        </div>
       </div>
       <div id="topicWhatsNewContainer">
       </div>
       <div id="topicText">
        <p class="headingAnchor" id="H1">
         <span class="h1">
          INTRODUCTION
         </span>
         <span class="headingEndMark">
          —
         </span>
         There are a number of inborn errors of glucose and glycogen metabolism (dextrinosis and glycogenosis) that result from pathogenic variants in genes for virtually all of the proteins involved in glycogen synthesis, degradation, or regulation. Those disorders that result in abnormal storage of glycogen are known as glycogen storage diseases (GSDs). They are largely categorized by number according to the chronology of recognition of the responsible enzyme defect  (
         <a class="graphic graphic_table graphicRef54417" href="/z/d/graphic/54417.html" rel="external">
          table 1
         </a>
         ). The age of onset varies from in utero to adulthood.
        </p>
        <p>
         This topic review provides a brief overview of the inherited disorders of glucose and glycogen metabolism (glycogenoses). The individual disorders are discussed separately in the appropriate topic reviews.
        </p>
        <p class="headingAnchor" id="H600479084">
         <span class="h1">
          PHYSIOLOGY
         </span>
         <span class="headingEndMark">
          —
         </span>
         Glycogen is the stored form of glucose and serves as a buffer for glucose needs. It is composed of long polymers of a 1-4 linked glucose, interrupted by a 1-6 linked branch point every 4 to 10 residues. Glycogen is formed during periods of dietary carbohydrate loading and broken down when glucose demand is high or dietary availability is low  (
         <a class="graphic graphic_figure graphicRef81164" href="/z/d/graphic/81164.html" rel="external">
          figure 1
         </a>
         ).
        </p>
        <p>
         Glycogen is most abundant in the liver and muscle and plays the following roles:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         The main role of glycogen in the liver is to maintain glucose homeostasis. The liver stores glucose for release to tissues that are unable to synthesize significant amounts during fasting.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         In muscle, glycogen is a source of energy for high-intensity muscle activity. Glycogen breakdown provides substrates for the generation of adenosine triphosphate (ATP).
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2">
         <span class="h1">
          CLINICAL AND LABORATORY FEATURES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The liver and skeletal muscle are most affected by disorders of glucose and glycogen metabolism. The physiologic importance of the defective enzyme in liver and muscle  (
         <a class="graphic graphic_table graphicRef54417" href="/z/d/graphic/54417.html" rel="external">
          table 1
         </a>
         ) determines the clinical manifestations of the disease. The major manifestations of disorders of glycogen metabolism affecting the liver are hypoglycemia and hepatomegaly  (
         <a class="graphic graphic_table graphicRef51949" href="/z/d/graphic/51949.html" rel="external">
          table 2
         </a>
         ) and, for those affecting muscle, are muscle cramps, exercise intolerance and easy fatigability, progressive weakness, and variable cardiac involvement with cardiomyopathy and conduction defects  (
         <a class="graphic graphic_table graphicRef106089" href="/z/d/graphic/106089.html" rel="external">
          table 3
         </a>
         ) [
         <a href="#rid1">
          1
         </a>
         ]. Some forms of these disorders may have both liver and muscle findings along with less common complications of neurologic involvement and hemolysis. GSD type IV (branching enzyme deficiency) is uniquely pleiotropic, with clinical presentations ranging from fetal hydrops to adult-onset neurodegeneration. There is both liver disease, with progressive cirrhosis but typically no hypoglycemia, and neuromuscular involvement in glycogen storage disease (GSD) IV [
         <a href="#rid2">
          2
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H3">
         <span class="h2">
          Hypoglycemia in patients with liver involvement
         </span>
         <span class="headingEndMark">
          —
         </span>
         The main role of glycogen in the liver is to store glucose for release to tissues that are unable to synthesize significant amounts during fasting. Patients with a disorder of hepatic glycogen metabolism typically present with fasting hypoglycemia and ketosis with or without hepatomegaly. Their symptoms improve with eating or glucose administration. These children may have poor weight gain but are usually developmentally normal.
        </p>
        <p>
         The diagnostic approach to hypoglycemia in infants, children, and newborns is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/5805.html" rel="external">
          "Approach to hypoglycemia in infants and children"
         </a>
         and
         <a class="medical medical_review" href="/z/d/html/5053.html" rel="external">
          "Pathogenesis, screening, and diagnosis of neonatal hypoglycemia"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H4">
         <span class="h2">
          Muscle symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         Glycogen is the primary source of energy for high-intensity muscle activity by providing substrates for the generation of adenosine triphosphate (ATP). Whereas defects in fatty acid metabolism cause symptoms after prolonged exercise, glycolytic defects usually present with symptoms after short periods of moderate-to-intense exercise. The major manifestations of disorders of glycogen metabolism affecting muscle fall into two main categories:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Exercise intolerance with muscle pain, cramps, rhabdomyolysis, and myoglobinuria
         </strong>
         – These symptoms are usually associated with defects of glycogenolysis or glycolysis.
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Progressive weakness involving trunk and extremity muscles
         </strong>
         – This manifestation is more typical of defects in lysosomal glycogenolysis (acid maltase and lysosome-associated membrane protein 2 [LAMP2] deficiencies) and also of defects in the glycogen synthesis pathway (glycogenin and brancher enzyme deficiency).
        </p>
        <p>
        </p>
        <p>
         There are exceptions, however, because defects in certain glycogenolytic and glycolytic enzymes (eg, myophosphorylase, debrancher, phosphorylase kinase, phosphofructokinase) may present with weakness rather than cramps, and myoglobinuria or fixed weakness may develop later in life. Conversely, muscle glycogen synthetase deficiency may cause exercise intolerance [
         <a href="#rid3">
          3
         </a>
         ].
        </p>
        <p>
         The diagnostic approach to a patient with a suspected metabolic myopathy is discussed separately. (See
         <a class="medical medical_review" href="/z/d/html/6193.html" rel="external">
          "Approach to the metabolic myopathies"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H3283908561">
         <span class="h2">
          Muscle and heart symptoms
         </span>
         <span class="headingEndMark">
          —
         </span>
         A few GSDs can affect both skeletal muscle and myocardium and therefore may result in both muscle symptoms and cardiomyopathy. The two main disorders are defects in lysosomal acid maltase and LAMP2 but also two rarer GSDs, glycogenin I deficiency and muscle glycogen synthase deficiency [
         <a href="#rid4">
          4
         </a>
         ].
        </p>
        <p class="headingAnchor" id="H5">
         <span class="h1">
          CLASSIFICATION
         </span>
         <span class="headingEndMark">
          —
         </span>
         Fifteen types of glycogen storage diseases (GSDs) have been identified  (
         <a class="graphic graphic_table graphicRef54417" href="/z/d/graphic/54417.html" rel="external">
          table 1
         </a>
         ). In a review of 1438 patients in a series from the United States and Europe, five GSDs accounted for 94 percent of cases: GSD I, GSD III, GSD VI, GSD IX (formerly VIII; all of which involve the liver), and GSD II, which involves skeletal muscle  (
         <a class="graphic graphic_table graphicRef66250" href="/z/d/graphic/66250.html" rel="external">
          table 4
         </a>
         ) [
         <a href="#rid5">
          5
         </a>
         ]. Two other rare disorders of glycogen metabolism are glucose transporter 2 (GLUT2) deficiency and aldolase A deficiency. The functions of the enzymes and clinical characteristics of many of the individual disorders are discussed in detail separately.
        </p>
        <p class="headingAnchor" id="H6">
         <span class="h2">
          Liver disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following inherited disorders of glucose and glycogen metabolism primarily involve the liver:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glycogen synthase-2 deficiency (GSD 0a) (see
         <a class="medical medical_review" href="/z/d/html/2947.html" rel="external">
          "Liver glycogen synthase deficiency (glycogen storage disease 0)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucose-6-phosphatase deficiency (GSD Ia) (see
         <a class="medical medical_review" href="/z/d/html/2946.html" rel="external">
          "Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glucose-6-phosphate transporter deficiency (GSD Ib) (see
         <a class="medical medical_review" href="/z/d/html/2946.html" rel="external">
          "Glucose-6-phosphatase deficiency (glycogen storage disease I, von Gierke disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glycogen debrancher deficiency (GSD III) (see
         <a class="medical medical_review" href="/z/d/html/2906.html" rel="external">
          "Glycogen debrancher deficiency (glycogen storage disease III, Cori disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Liver phosphorylase deficiency (GSD VI) (see
         <a class="medical medical_review" href="/z/d/html/2944.html" rel="external">
          "Liver phosphorylase deficiency (glycogen storage disease VI, Hers disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Phosphorylase kinase deficiency (GSD IXa1, formerly GSD VIII; GSD IXb-d) (see
         <a class="medical medical_review" href="/z/d/html/2908.html" rel="external">
          "Phosphorylase b kinase deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         GLUT2 deficiency (Fanconi-Bickel syndrome) [
         <a href="#rid6">
          6
         </a>
         ] (see
         <a class="medical medical_review" href="/z/d/html/2914.html" rel="external">
          "Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H7">
         <span class="h2">
          Skeletal muscle disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following inherited disorders of glucose and glycogen metabolism primarily involve skeletal muscle:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Muscle phosphorylase deficiency (GSD V) (see
         <a class="medical medical_review" href="/z/d/html/2909.html" rel="external">
          "Myophosphorylase deficiency (glycogen storage disease V, McArdle disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Phosphofructokinase deficiency (GSD VII) (see
         <a class="medical medical_review" href="/z/d/html/2907.html" rel="external">
          "Phosphofructokinase deficiency (glycogen storage disease VII, Tarui disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Phosphoglycerate kinase deficiency (see
         <a class="medical medical_review" href="/z/d/html/2911.html" rel="external">
          "Phosphoglycerate kinase deficiency and phosphoglycerate mutase deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Phosphoglycerate mutase deficiency (GSD X) (see
         <a class="medical medical_review" href="/z/d/html/2911.html" rel="external">
          "Phosphoglycerate kinase deficiency and phosphoglycerate mutase deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lactate dehydrogenase A deficiency (GSD XI) (see
         <a class="medical medical_review" href="/z/d/html/2913.html" rel="external">
          "Lactate dehydrogenase deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Aldolase A deficiency (GSD XII) (see
         <a class="medical medical_review" href="/z/d/html/2914.html" rel="external">
          "Other disorders of glycogen metabolism: GLUT2 deficiency and aldolase A deficiency"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Beta-enolase deficiency (GSD XIII)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Phosphoglucomutase-1 deficiency (GSD XIV) [
         <a href="#rid7">
          7
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         RANBP2-type and C3HC4-type zinc finger containing 1 (RBCK1) deficiency [
         <a href="#rid3">
          3
         </a>
         ]
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H2380204787">
         <span class="h2">
          Skeletal and cardiac muscle disorders
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following inherited disorders involve both skeletal muscle and myocardium:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lysosomal acid maltase deficiency (formerly GSD II) (see
         <a class="medical medical_review" href="/z/d/html/2905.html" rel="external">
          "Lysosomal acid alpha-glucosidase deficiency (Pompe disease, glycogen storage disease II, acid maltase deficiency)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glycogen branching enzyme deficiency (GSD IV) (see
         <a class="medical medical_review" href="/z/d/html/2937.html" rel="external">
          "Glycogen branching enzyme deficiency (glycogen storage disease IV, Andersen disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Lysosome-associated membrane protein 2 (LAMP2) deficiency (formerly GSD IIb) (see
         <a class="medical medical_review" href="/z/d/html/2916.html" rel="external">
          "Lysosome-associated membrane protein 2 deficiency (glycogen storage disease IIb, Danon disease)"
         </a>
         )
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Glycogenin-1 deficiency (GSD XV)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         Muscle glycogen synthase deficiency (GSD 0b)
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H25290820">
         <span class="h1">
          INTERNET RESOURCES
         </span>
         <span class="headingEndMark">
          —
         </span>
         The following websites have information available for clinicians and patients:
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.agsdus.org%2F&amp;token=IQxLzDq4doJGUgaZgeIY0xVNGZvYpH0pjxfDxyEkDm4%3D&amp;TOPIC_ID=2941" target="_blank">
          Association for Glycogen Storage Disease
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.marchofdimes.org%2F&amp;token=5yLNPmHjkOhvnhOBCCm6DCX%2Fjjq3xEOZMgswac2czvDrESiZxI0nwkjwgYG0ulsn&amp;TOPIC_ID=2941" target="_blank">
          March of Dimes
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.mda.org%2F&amp;token=5yLNPmHjkOhvnhOBCCm6DE7VGu9ZZuQdpEWXw3mRscA%3D&amp;TOPIC_ID=2941" target="_blank">
          Muscular Dystrophy Association
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Frarediseases.org%2F&amp;token=9E9IX7kiH9qRiTPgEvfhBeYjQOtPjl2OjGky4jLGFuLb510NH1k3XPz57jIaCL1j&amp;TOPIC_ID=2941" target="_blank">
          National Organization for Rare Disorders (NORD)
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1116%2F&amp;token=wEsKVFvqlKzpT%2BqOtddW%2Fy3%2BLj0shalBW%2BL1ZyL4trzEAfmGCQvouTQ5LbX9C3XVSHxjYdvs2mgciTuJx4IXLQ%3D%3D&amp;TOPIC_ID=2941" target="_blank">
          GeneReviews
         </a>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <a class="external" href="/external-redirect?target_url=https%3A%2F%2Fmedlineplus.gov%2Fgenetics%2F&amp;token=d5ngiCbB8xFYJWkFI1xceo3ijUvGEfwS6w%2F%2BGm%2F2z9Vxi6nT3OOYTMsoEHReJre0&amp;TOPIC_ID=2941" target="_blank">
          Genetics Home Reference
         </a>
        </p>
        <p>
        </p>
        <p class="headingAnchor" id="H1193884730">
         <span class="h1">
          SOCIETY GUIDELINE LINKS
         </span>
         <span class="headingEndMark">
          —
         </span>
         Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See
         <a class="medical medical_society_guidelines" href="/z/d/html/118189.html" rel="external">
          "Society guideline links: Glycogen storage disease types I and II"
         </a>
         .)
        </p>
        <p class="headingAnchor" id="H9">
         <span class="h1">
          SUMMARY
         </span>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Overview
         </strong>
         – Glycogen is the stored form of glucose and serves as a buffer for glucose needs. It is formed in periods of dietary carbohydrate loading and broken down when glucose demand is high or dietary availability is low  (
         <a class="graphic graphic_figure graphicRef81164" href="/z/d/graphic/81164.html" rel="external">
          figure 1
         </a>
         ). (See
         <a class="local">
          'Introduction'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Types of glycogen storage diseases
         </strong>
         – Inherited disorders that result in abnormal storage of glycogen are known as glycogen storage diseases (GSDs). GSDs have largely been categorized by number according to the chronology of recognition of the responsible enzyme defect  (
         <a class="graphic graphic_table graphicRef54417" href="/z/d/graphic/54417.html" rel="external">
          table 1
         </a>
         ). The age of onset varies from birth to adulthood. (See
         <a class="local">
          'Classification'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features in patients with liver involvement
         </strong>
         – A disorder of hepatic glycogen metabolism should be considered in patients who present with fasting hypoglycemia and ketosis, with or without hepatomegaly, and whose symptoms improve with eating or glucose administration  (
         <a class="graphic graphic_table graphicRef51949" href="/z/d/graphic/51949.html" rel="external">
          table 2
         </a>
         ). (See
         <a class="local">
          'Hypoglycemia in patients with liver involvement'
         </a>
         above.)
        </p>
        <p>
        </p>
        <p class="bulletIndent1">
         <span class="glyph">
          ●
         </span>
         <strong>
          Clinical features in patients with muscle involvement
         </strong>
         – The major manifestations of disorders of glycogen metabolism affecting muscle appear after short periods of moderate-to-intense exercise. There are two typical categories of presentation: exercise intolerance with muscle pain, cramps, rhabdomyolysis, and myoglobinuria and progressive weakness involving trunk and extremity muscles. A few GSDs affect both skeletal muscle and myocardium and may result in both muscle symptoms and cardiomyopathy. (See
         <a class="local">
          'Muscle symptoms'
         </a>
         above and
         <a class="local">
          'Muscle and heart symptoms'
         </a>
         above.)
        </p>
        <p>
        </p>
       </div>
       <div class="headingAnchor" id="references">
        <ol id="reference">
         <li>
          <a class="nounderline abstract_t">
           Tarnopolsky MA. Metabolic Myopathies. Continuum (Minneap Minn) 2022; 28:1752.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Koch RL, Soler-Alfonso C, Kiely BT, et al. Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource. Mol Genet Metab 2023; 138:107525.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Oldfors A, DiMauro S. New insights in the field of muscle glycogenoses. Curr Opin Neurol 2013; 26:544.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Derks TGJ, Moura de Souza. Glycogen storage diseases: Next-generation medicine. J Inborn Errors Metab Screen 2017; 5:1.
          </a>
         </li>
         <li class="breakAll">
          Kishnani PS, Chen YT. Disorders of glycogen metabolism. In: Rudolph's Pediatrics, 23rd ed, Kline MW, Blaney SM. Giardino AP, et al (Eds), McGraw-Hill Education, 2018.
         </li>
         <li>
          <a class="nounderline abstract_t">
           Hannah WB, Derks TGJ, Drumm ML, et al. Glycogen storage diseases. Nat Rev Dis Primers 2023; 9:46.
          </a>
         </li>
         <li>
          <a class="nounderline abstract_t">
           Tegtmeyer LC, Rust S, van Scherpenzeel M, et al. Multiple phenotypes in phosphoglucomutase 1 deficiency. N Engl J Med 2014; 370:533.
          </a>
         </li>
        </ol>
       </div>
       <div id="topicVersionRevision">
        Topic 2941 Version 14.0
       </div>
      </div>
      <div class="row">
       <div class="col-12">
        <h4 style="text-align: center;padding: 20px;color: cadetblue;">
         References
        </h4>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36537979" id="rid0" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          1 : Metabolic Myopathies.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/36796138" id="rid1" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          2 : Diagnosis and management of glycogen storage disease type IV, including adult polyglucosan body disease: A clinical practice resource.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/23995275" id="rid2" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          3 : New insights in the field of muscle glycogenoses.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid3" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          4 : Glycogen storage diseases: Next-generation medicine
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/" id="rid4" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          5 : Glycogen storage diseases: Next-generation medicine
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/37679331" id="rid5" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          6 : Glycogen storage diseases.
         </p>
        </a>
       </div>
       <div class="col-12" style="text-align: left;direction: ltr">
        <a href="https://pubmed.ncbi.nlm.nih.gov/24499211" id="rid6" target="_blank">
         <p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>
          7 : Multiple phenotypes in phosphoglucomutase 1 deficiency.
         </p>
        </a>
       </div>
      </div>
     </div>
    </div>
   </section>
  </section>
  <!-- End Main Menu Area -->
  <!-- Start Search Popup Area -->
  <!-- End Footer Area -->
  <!-- Back to top -->
  <a class="scrolltop" href="#top">
   <i class="icofont-hand-drawn-up">
   </i>
  </a>
  <!-- End Back to top -->
  <!-- jQuery Min JS -->
  <!-- Prpper JS -->
  <!-- Bootstrap Min JS -->
  <!-- Classy Nav Min Js -->
  <!-- Owl Carousel Min Js -->
  <!-- Magnific Popup JS -->
  <!-- CounterUp JS -->
  <!-- Waypoints JS -->
  <!-- Form Validator Min JS -->
  <!-- Contact Form Min JS -->
  <!-- Main JS -->
  <!-- Global site tag (gtag.js) - Google Analytics -->
 </body>
</html>
